Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4GA3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,665
Award facts
- Contract value 100% obligated
- $15,664.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,664.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen 2 ml on January 6, 2026, with an ultimate completion date of January 7, 2026. This non-set-aside competitive award will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Cosentyx is a biologic immunosuppressant medication primarily used to treat autoimmune and inflammatory conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis, supporting the Defense Health Agency's pharmaceutical supply requirements for military treatment facilities and beneficiaries.
This delivery order represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. As a leading pharmaceutical distributor, AmerisourceBergen serves as a critical vendor within the federal medical supply chain, delivering a comprehensive range of prescription medications, specialty pharmaceuticals, and medical supplies to military healthcare systems worldwide. The firm fixed-price structure and rapid completion timeline reflect the routine procurement model employed for essential pharmaceutical commodities supporting ongoing government healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F4GA3?
SPE2DR26F4GA3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F4GA3 worth?
The government has obligated $15,665 on SPE2DR26F4GA3.
Is contract SPE2DR26F4GA3 an order under another contract?
Yes. SPE2DR26F4GA3 is a delivery order under SPE2DR25D3015, an indefinite delivery contract.
Was contract SPE2DR26F4GA3 competed?
The extent of competition for SPE2DR26F4GA3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award